A Single-Blind, Randomized, Placebo-Controlled Trial of Human Fecal Microbial Transplantation for the Therapy of Pediatric Ulcerative Colitis and Inflammatory Bowel Disease Unclassified
Phase of Trial: Phase I
Latest Information Update: 22 Dec 2017
At a glance
- Drugs RBX 2660 (Primary)
- Indications Inflammatory bowel diseases; Ulcerative colitis
- Focus Therapeutic Use
- Acronyms PediFETCh
- 17 Dec 2017 Planned End Date changed from 1 Dec 2017 to 1 Jul 2018.
- 17 Dec 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Jul 2018.
- 10 Jun 2017 Biomarkers information updated